Hypnotic and cardiovascular effects of proprietary and generic propofol formulations do not differ

Canadian Journal of Anesthesia

Volumn 48, Issue 5, 2001, Pages 459-461

  Fassoulaki, Argyro ^a   Paraskeva, Andia ^a   Papilas, Konstantinos ^a   Patris, Konstantinos ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; GENERIC DRUG; NITROUS OXIDE; OXYGEN; PROPOFOL; ROCURONIUM;

ARTERIAL OXYGEN SATURATION; ARTICLE; BOLUS INJECTION; BREAST SURGERY; CALCULATION; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG FORMULATION; DRUG MONITORING; DRUG POTENCY; FEMALE; HEART RATE; HUMAN; HYPNOSIS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TIDAL VOLUME;

EID: 0034949790     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03028308     Document Type: Article

References (7)

1. Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia
2. A primer for EEG signal processing in anesthesia
3. Hypnotic endpoints vs. the bispectral index, 95% spectral edge frequency and median frequency during propofol infusion with or without fentanyl
4. The effect of the interaction of propofol and alfentanil on recall, loss of consciousness, and the bispectral index
5. Nitrous oxide does not alter bispectral index: Study with nitrous oxide as a sole agent and as an adjunct to i.v. anaesthesia
6. What does the bispectral EEG index monitor?
7. Evaluation of the electroencephalographic bispectral index during fentanyl-midazolam anaesthesia for cardiac surgery. Does it predict haemodynamic responses during endotracheal intubation and sternotomy?